Fingerpaint Group

Articles

How Data Shapes the Future of Omnichannel Marketing

Prioritizing Safety and Medication Error Prevention When Creating and Choosing a Trade Name 

Unlocking a New Era of Key Opinion Leader Engagement: The Power of Digital Voices

We’re 220+ strong, fully independent, and ready to handle any healthcare marketing challenge you care to throw at us.

Price Transparency: Does the Pharmaceutical Industry Need to Prepare Today for the Implications of Price Transparency on Commercialization and Market Access?

How these actions can help brand teams form effective and sustainable relationships with patient communities

3 Steps to Supercharge Your Rare Disease Advocacy Partnerships

3 Bold Moves to Stand Out in Rare Disease Branding

An evolving system requires a focus on digital channels

Integrating Payers Into Your Digital Communication Plan

Why it’s important to integrate patient assistance programs for cell and gene therapies into the overall clinical development plan.

Patient Support Design is Critical for Cell and Gene Therapies

Molly Hudish is a brand strategist in Fingerpaint’s Conshohocken, Pa., office. She can be reached at 

Resonating With the Emerging Gen Z HCP

As the world determines how best to function in a COVID-19 world, it is all but certain that some level of safety measures will continue for the foreseeable future.